|
1
|
Levey AS, Eckardt KU, Tsukamoto Y, et al:
Definition and classification of chronic kidney disease: a position
statement from Kidney Disease: Improving Global Outcomes (KDIGO).
Kidney Int. 67:2089–2100. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Meguid El Nahas A and Bello AK: Chronic
kidney disease: the global challenge. Lancet. 365:331–340.
2005.
|
|
3
|
Weiner DE, Tighiouart H, Amin MG, et al:
Chronic kidney disease as a risk factor for cardiovascular disease
and all-cause mortality: a pooled analysis of community-based
studies. J Am Soc Nephrol. 15:1307–1315. 2004. View Article : Google Scholar
|
|
4
|
Couser WG, Remuzzi G, Mendis S and Tonelli
M: The contribution of chronic kidney disease to the global burden
of major noncommunicable diseases. Kidney Int. 80:1258–1270. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kohro T, Furui Y, Mitsutake N, et al: The
Japanese national health screening and intervention program aimed
at preventing worsening of the metabolic syndrome. Int Heart J.
49:193–203. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boulware LE, Jaar BG, Tarver-Carr ME,
Brancati FL and Powe NR: Screening for proteinuria in US adults: a
cost-effectiveness analysis. JAMA. 290:3101–3114. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kondo M, Yamagata K, Hoshi SL, et al:
Cost-effectiveness of chronic kidney disease mass screening test in
Japan. Clin Exp Nephrol. 16:279–291. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iseki K: The okinawa screening program. J
Am Soc Nephrol. 14:S127–S130. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Haroun MK, Jaar BG, Hoffman SC, Comstock
GW, Klag MJ and Coresh J: Risk factors for chronic kidney disease:
a prospective study of 23,534 men and women in Washington County,
Maryland. J Am Soc Nephrol. 14:2934–2941. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamagata K, Ishida K, Sairenchi T, et al:
Risk factors for chronic kidney disease in a community-based
population: a 10-year follow-up study. Kidney Int. 71:159–166.
2007.PubMed/NCBI
|
|
11
|
Klag MJ, Whelton PK, Randall BL, et al:
Blood pressure and end-stage renal disease in men. N Engl J Med.
334:13–18. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
O’Seaghdha CM, Parekh RS, Hwang SJ, et al:
The MYH9/APOL1 region and chronic kidney disease in
European-Americans. Hum Mol Genet. 20:2450–2456. 2011.PubMed/NCBI
|
|
13
|
Chow KM, Wong TY and Li PK: Genetics of
common progressive renal disease. Kidney Int Suppl. 94:S41–S45.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Köttgen A, Pattaro C, Böger CA, et al: New
loci associated with kidney function and chronic kidney disease.
Nat Genet. 42:376–384. 2010.
|
|
15
|
Okada Y, Sim X, Go MJ, et al:
Meta-analysis identifies multiple loci associated with kidney
function-related traits in East Asian populations. Nat Genet.
44:904–909. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamada Y, Nishida T, Ichihara S, et al:
Association of a polymorphism of BTN2A1 with myocardial infarction
and dyslipidemia in East Asian populations. Atherosclerosis.
215:145–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matsuo S, Imai E, Horio M, et al: Revised
equations for estimated GFR from serum creatinine in Japan. Am J
Kidney Dis. 53:982–992. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
National Kidney Foundation. K/DOQI
clinical practice guidelines for chronic kidney disease:
evaluation, classification, and stratification. Am J Kidney Dis.
39:S1–S266. 2002.PubMed/NCBI
|
|
19
|
Itoh Y, Mizuki N, Shimada T, et al:
High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a
PCR-SSOP-Luminex method in the Japanese population. Immunogenetics.
57:717–729. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoshida T, Kato K, Horibe H, et al:
Association of a genetic variant of BTN2A1 with chronic kidney
disease in Japanese individuals. Nephrology. 16:642–648.
2011.PubMed/NCBI
|
|
21
|
Ogg SL, Weldon AK, Dobbie L, Smith AJ and
Mather IH: Expression of butyrophilin (Btn1a1) in lactating mammary
gland is essential for the regulated secretion of milk-lipid
droplets. Proc Natl Acad Sci USA. 101:10084–10089. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arnett HA, Escobar SS and Viney JL:
Regulation of costimulation in the era of butyrophilins. Cytokine.
46:370–375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oguri M, Kato K, Yoshida T, et al:
Association of a genetic variant of BTN2A1 with metabolic syndrome
in East Asian populations. J Med Genet. 48:787–792. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Harris RC and Neilson EG: Toward a unified
theory of renal progression. Annu Rev Med. 57:365–380. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schnaper HW and Kopp JB: Why kidneys fail:
report from an American Society of Nephrology Advances in Research
Conference. J Am Soc Nephrol. 17:1777–1781. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ricardo SD, van Goor H and Eddy AA:
Macrophage diversity in renal injury and repair. J Clin Invest.
118:3522–3530. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brosius FC III: New insights into the
mechanisms of fibrosis and sclerosis in diabetic nephropathy. Rev
Endocr Metab Disord. 9:245–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
